Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0858 USD | +50.53% | +25.26% | -6.74% |
03-29 | Inhibitor Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Introducing Inhibitor Therapeutics, Inc. Announces Scientific Advisory Board | CI |
Quotes 5-day view
Delayed Quote OTC Markets23/04/2024 | 24/04/2024 | |
---|---|---|
Last | 0.057 $ | 0.0858 $ |
Volume | 100 | 250 |
Change | +∞% | +50.53% |
Opening | 0.06 | 0.09 |
High | 0.06 | 0.09 |
Low | 0.06 | 0.09 |
Performance
1 day | +50.53% | ||
1 week | +25.26% | ||
Current month | +22.57% | ||
1 month | +22.57% | ||
3 months | -14.20% | ||
6 months | +66.60% | ||
Current year | -6.74% | ||
1 year | +115.58% | ||
3 years | +32.00% | ||
5 years | +61.28% | ||
10 years | -59.14% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Bio Therapeutic Drugs
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+50.53% | +25.26% | -6.74% | +115.58% | 14.76M | ||
-0.06% | +0.81% | -2.31% | +17.12% | 103B | ||
-0.84% | -1.52% | +0.56% | +11.47% | 95.28B | ||
+0.90% | +3.56% | +1.69% | +1.90% | 22.15B | ||
+0.58% | +0.46% | -17.37% | -21.94% | 21.02B | ||
+2.04% | -2.57% | -9.30% | -29.08% | 18.15B | ||
+3.17% | +1.71% | -41.01% | -36.05% | 16.73B | ||
+3.38% | +18.58% | -14.85% | -39.89% | 16.05B | ||
-1.28% | +3.02% | +3.21% | +33.45% | 13.68B | ||
+1.08% | +11.37% | +33.54% | +5.44% | 12.17B | ||
+1.98% | -1.93% | -24.71% | -34.18% | 8.24B | ||
+7.91% | +17.17% | +299.30% | +278.94% | 8.19B | ||
-0.75% | -3.05% | +7.90% | +76.54% | 7.76B | ||
+0.95% | +0.62% | +0.17% | +49.70% | 7.71B | ||
+5.81% | +6.81% | -54.46% | -71.56% | 7.17B | ||
+0.72% | +5.24% | -1.21% | +30.43% | 6.99B | ||
Average | +4.76% | +5.36% | +10.90% | +24.24% | ||
Weighted average by Cap. | +0.59% | +1.87% | +2.09% | +10.63% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -6.74% | ||
2023 | -6.84% | ||
2022 | -34.06% | ||
2021 | +328.47% | ||
2020 | -37.31% | ||
2019 | -7.08% | ||
2018 | -76.10% | ||
2017 | -35.64% | ||
2016 | +200.00% | ||
2015 | +4.00% | ||
2014 | +52.44% | ||
2013 | +446.67% | ||
2012 | +15.38% | ||
2011 | -79.03% | ||
2010 | -83.90% | ||
2009 | +48.15% | ||
2008 | -89.80% | ||
2007 | +19.16% | ||
2006 | -55.42% | ||
2005 | -20.00% | ||
2004 | +86.92% | ||
2003 | +372.06% | ||
2002 | -75.00% | ||
2001 | -27.47% | ||
2000 | -59.04% | ||
1999 | +6.16% | ||
1998 | +2.99% | ||
1997 | -5.63% |
- Stock Market
- Equities
- INTI Stock
- Quotes Inhibitor Therapeutics, Inc.